Skip to main content
Skip to main content
IMHC logo

Imperalis Holding Corp. (IMHC) Stock Analysis

$0.011 +$0.0009 (+8.91%) |CouncilBearish Lean · 26 · F
Imperalis Holding Corp. (IMHC) bottom line: signals are mixed — the Council read leans Bearish Lean (26/100) while the AI fundamental score is 0/100 (grade F); the two lenses disagree, so weigh the breakdown below. Strongest signal: Jim Simons bullish · Biggest watch-out: Ken Griffin bearish.
MCap: $2.30M| Vol: 957.8K| 52-wk range: $0.0013 – $0.14
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Imperalis Holding Corp. (IMHC) trades at $0.011. Imperalis Holding Corp. is a shell company with no significant current operations, previously involved in CBD-based personal care products. The company is a subsidiary of BitNile, Inc. Market cap: $2.30M, Sector: Financial services.

Price as of Aug 21, 2026 · Last analyzed: Mar 18, 2026
Imperalis Holding Corp. is a shell company with no significant current operations, previously involved in CBD-based personal care products. The company is a subsidiary of BitNile, Inc. and is headquartered in Las Vegas, Nevada.

Analyst Coverage for IMHC: IMHC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates IMHC against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Watch the IMHC film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Bearish Lean 26/100 · F

IMHC: 1/2 scored disciplines lean bearish. Dominant signal: Ken Griffin bearish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Ken Griffin
Bearish
Jim Simons
Bullish
Izzy Englander
Neutral
Seth Klarman
Bearish
Moon AI
Neutral
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Imperalis Holding Corp. (IMHC) Financial Services Profile

CEOAmos Kohn
Employees22
HeadquartersLas Vegas, US
IPO Year2007

Imperalis Holding Corp., a shell company within the Financial Services sector, lacks significant ongoing operations, having previously focused on CBD-based personal care products through its subsidiary, CannaCure Sciences. As a subsidiary of BitNile, Inc., IMHC's future direction and potential ventures remain uncertain, operating with a small team of 22 employees.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 18, 2026

What Is the Investment Thesis for IMHC?

As of Mar 18, 2026 — figures reflect the data available on that date.

Imperalis Holding Corp. (IMHC) presents a speculative investment opportunity given its status as a shell company. With a market capitalization of $2.30M and negative profitability (P/E of -1.78 and a profit margin of -56.3%), the company's financials reflect its lack of current operations. The absence of a dividend further underscores the speculative nature of the investment. Potential catalysts include the identification of a new business venture or a strategic acquisition. However, the lack of current operations and reliance on its parent company, BitNile, Inc., pose significant risks. Investors should carefully consider the high-risk, high-reward profile associated with IMHC, focusing on any announcements regarding future business plans or strategic shifts. Monitoring BitNile's strategic decisions is also crucial.

Based on FMP financials and quantitative analysis

IMHC Key Highlights

Market Cap of $2.30M reflects its status as a shell company with no significant operations.

  • Negative P/E Ratio of -1.78 indicates the company is not currently profitable.
  • Profit Margin of -56.3% highlights the financial challenges due to the lack of active business operations.
  • Gross Margin of 39.6% reflects the historical performance of its previous CBD-based product line, though these operations are no longer significant.
  • Beta of 0.50 suggests lower volatility compared to the overall market, potentially due to the limited trading activity associated with a shell company.

Who Are IMHC's Competitors?

IMHC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
NIHL New Infinity Holdings, Ltd. $0.10 +0.00% $10.8M 62
LRGR Luminar Media Group, Inc. $0.50 +47.06% $22.4M 68
CLAYU Chavant Capital Acquisition Corp. $10.97 +18.34% $27.5M 62
CLAY Chavant Capital Acquisition Corp. $10.66 +6.39% $29.6M 62
INACU Indigo Acquisition Corp. $12.08 +16.94% $34.9M 60
HHGC HHG Capital Corporation $11.12 +0.09% $56.2M 63
MAAQ Mana Capital Acquisition Corp. $5.99 -24.18% $57.0M 61
RCLFU Rosecliff Acquisition Corp I $11.33 +11.74% $77.2M 62

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are IMHC's Key Strengths?

Existing corporate structure.

  • Subsidiary of BitNile, Inc., providing potential access to resources.
  • Previous experience in the CBD market (though currently inactive).
  • Publicly listed company, facilitating potential mergers or acquisitions.

What Are IMHC's Weaknesses?

Lack of current operations and revenue generation.

  • Reliance on parent company, BitNile, Inc., for strategic direction.
  • Limited brand recognition due to inactivity.
  • Uncertainty regarding future business plans.

What Could Drive IMHC Stock Higher?

IMHC catalyst: Announcement of a new business venture or acquisition target (timeline: within the next 6-12 months).

  • Completion of a strategic partnership agreement (timeline: within the next 3-6 months).
  • Efforts to secure funding for future business initiatives.
  • Exploration of potential restructuring options.

What Are the Key Risks for IMHC?

Financial-distress signal — its Altman Z-Score of -15.03 sits in the distress zone (elevated bankruptcy risk).

  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
  • Failure to identify and execute a successful strategic transaction.
  • Market conditions impacting capital raising efforts.
  • Regulatory changes affecting shell companies and reverse mergers.
  • Limited financial disclosure and transparency due to OTC listing.
  • Low trading volume and liquidity, increasing price volatility.

What Are the Growth Opportunities for IMHC?

  • Acquisition Target Identification: Imperalis Holding Corp. could focus on identifying and acquiring a promising private company seeking to go public. The market for reverse mergers remains active, with numerous private companies across various sectors looking for efficient ways to access public markets. Successfully acquiring a high-growth company could significantly increase shareholder value, with potential timelines varying depending on deal sourcing and due diligence, estimated within 12-24 months.
  • Strategic Partnership Formation: Forming a strategic partnership with a company in a high-growth sector, such as technology or renewable energy, could provide Imperalis Holding Corp. with access to new markets and technologies. This could involve a joint venture or a licensing agreement, allowing IMHC to leverage its existing corporate structure. The timeline for establishing such a partnership could range from 6-18 months, depending on the complexity of the agreement.
  • Restructuring and Business Overhaul: Imperalis Holding Corp. could undergo a complete restructuring and business overhaul, pivoting to a new industry or business model. This would involve divesting any remaining assets from its previous operations and investing in a new venture. The timeline for such a transformation could be 12-36 months, requiring significant capital investment and strategic planning.
  • Capital Raising Initiatives: Imperalis Holding Corp. could initiate capital raising efforts to fund future acquisitions or business ventures. This could involve issuing new shares of stock or securing debt financing. The success of these initiatives would depend on market conditions and investor confidence in the company's future prospects. The timeline for raising capital could range from 3-9 months, depending on the size and complexity of the offering.
  • Leveraging BitNile's Resources: As a subsidiary of BitNile, Inc., Imperalis Holding Corp. can leverage its parent company's resources and expertise to identify and pursue new business opportunities. This could involve accessing BitNile's network of contacts, utilizing its financial resources, or collaborating on strategic initiatives. The timeline for leveraging these resources would depend on the specific opportunity and the level of support provided by BitNile, potentially yielding results within 6-12 months.

What Are IMHC's Competitive Advantages?

  • Brand recognition (limited): Previously, CannaCure Sciences may have built some brand recognition within the CBD personal care market, but this is likely diminished due to the current lack of operations.
  • Access to capital: As a subsidiary of BitNile, Inc., Imperalis Holding Corp. has potential access to its parent company's financial resources.
  • Existing corporate structure: The company has an existing corporate structure and listing on the OTC market, which could facilitate a reverse merger or acquisition.

What Does IMHC Do?

Imperalis Holding Corp., formerly known as Coloured (US) Inc., was incorporated in 2005 and rebranded in March 2011. Headquartered in Las Vegas, Nevada, the company is currently a shell corporation, indicating it does not have substantial active business operations. Historically, Imperalis Holding Corp. engaged in the development, marketing, and sale of cannabidiol (CBD)-based personal care and cosmetic products through its subsidiary, CannaCure Sciences, Inc. However, these operations are no longer significant. The company's transition to a shell corporation suggests a strategic shift, potential restructuring, or exploration of new business opportunities. As a subsidiary of BitNile, Inc., Imperalis Holding Corp.'s strategic direction is influenced by its parent company. The company's current state presents both challenges and opportunities, as it seeks to redefine its role within the financial services landscape. With a small team of 22 employees, Imperalis Holding Corp. navigates its future endeavors, potentially exploring mergers, acquisitions, or a complete business overhaul.

What Products and Services Does IMHC Offer?

  • Currently functions as a shell company with no significant operations.
  • Previously engaged in the development, marketing, and sale of CBD-based personal care products.
  • Operated through its subsidiary, CannaCure Sciences, Inc.
  • Seeking potential new business ventures or acquisition targets.
  • Subsidiary of BitNile, Inc.

How Does IMHC Make Money?

  • Historically, generated revenue through the sale of CBD-based personal care products.
  • Currently, the business model is centered around identifying and executing a strategic transaction, such as a merger or acquisition.
  • Potential future revenue streams will depend on the nature of its new business venture.

What Industry Does IMHC Operate In?

Imperalis Holding Corp. operates within the shell company segment of the financial services sector. Shell companies are often characterized by their lack of active business operations and are sometimes used for mergers, acquisitions, or reverse takeovers. The competitive landscape includes other shell companies seeking similar opportunities. The market trends for shell companies are closely tied to the overall M&A activity and the availability of private companies seeking to go public. Given its current state, Imperalis Holding Corp.'s success depends on its ability to identify and execute a strategic transaction.

Who Are IMHC's Key Customers?

  • Historically, customers were individuals purchasing CBD-based personal care products.
  • Currently, the company does not have active customers.
  • Future customer base will depend on the nature of its new business venture.
AI Confidence: 71% Updated: Mar 18, 2026
ROE 17%

Key Financial Metrics

Return on equity for Imperalis Holding Corp. stands at 16.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -47.3%, showing how much profit it generates from its asset base. Its free cash flow yield is -16.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.26 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -47.6%, the inverse of the P/E and a quick read on earnings relative to price.

Imperalis Holding Corp. (IMHC) Valuation Context

Valued at $2.30M, IMHC is classified as a micro-cap stock.

Company Profile

Imperalis Holding Corp. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Las Vegas, US. The company is led by CEO Amos Kohn. IMHC has traded publicly since 2007.

F-Score 3/9

Financial Health

Imperalis Holding Corp.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -15.03 places it in the distress zone, a signal of elevated financial risk.

Net buying

Insider Activity

The most recent 11 insider filings for Imperalis Holding Corp. break down as 2 sales and 9 purchases. On net that is roughly 11.0M shares acquired (about $115K) — insiders putting money in tends to read as conviction.

IMHC Financials

Fundamental Snapshot

Revenue Growth (FY)
+47.1%
Net Income Growth (FY)
+46.8%
EPS Growth (FY)
+50.0%
Free Cash Flow Growth (FY)
+99.8%
Return on Equity (TTM)
+16.8%
Current Ratio
0.3

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Existing corporate structure.
  • Subsidiary of BitNile, Inc., providing potential access to resources.
  • Previous experience in the CBD market (though currently inactive).
  • Publicly listed company, facilitating potential mergers or acquisitions.

Bear Case

  • Lack of current operations and revenue generation.
  • Reliance on parent company, BitNile, Inc., for strategic direction.
  • Limited brand recognition due to inactivity.
  • Uncertainty regarding future business plans.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026

IMHC Latest News

No recent news available for IMHC.

IMHC Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for IMHC.

Price Targets

Wall Street price target analysis for IMHC.

IMHC MoonshotScore

0/100

What does this score mean?

The MoonshotScore rates IMHC 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.

Leadership: Amos Kohn

CEO

Amos Kohn serves as the CEO of Imperalis Holding Corp. His background includes experience in managing small teams and overseeing corporate operations. While specific details on his prior roles and education are not available, he brings leadership to the company during its transitional phase. He is responsible for guiding the company's strategic direction and exploring potential new business ventures.

Track Record: Under Amos Kohn's leadership, Imperalis Holding Corp. has focused on exploring strategic alternatives, given its current status as a shell company. His key decisions involve evaluating potential acquisition targets and assessing opportunities for restructuring. The company's future direction and success will depend on his ability to identify and execute a successful strategic transaction.

IMHC OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that Imperalis Holding Corp. may not meet the minimum financial standards or reporting requirements of the higher tiers (OTCQX and OTCQB). Companies in this tier often have limited trading volume and may be subject to greater price volatility. Investing in companies on the OTC Other tier carries significant risks due to the lack of regulatory oversight and the potential for fraud or manipulation. Investors should exercise extreme caution and conduct thorough due diligence before investing in IMHC.

  • OTC Tier: OTC Other
Liquidity: Liquidity for stocks on the OTC Other tier is typically very low. Bid-ask spreads can be wide, making it difficult to buy or sell shares at desired prices. The limited trading volume increases the risk of significant price fluctuations and makes it challenging to establish or exit a position. Investors should be prepared for potential delays in executing trades and the possibility of not being able to sell shares when desired.
OTC Risk Factors:
  • Limited financial disclosure and transparency.
  • Low trading volume and liquidity.
  • Potential for price manipulation and fraud.
  • Lack of regulatory oversight.
  • Higher risk of delisting or going out of business.
Due Diligence Checklist:
  • Verify the company's registration and legal standing.
  • Review available financial statements and disclosures.
  • Assess the company's management team and their track record.
  • Research the company's business model and potential market opportunities.
  • Evaluate the company's capital structure and debt levels.
  • Monitor trading volume and price activity.
  • Consult with a qualified financial advisor.
Legitimacy Signals:
  • Subsidiary of BitNile, Inc., providing some level of oversight.
  • Publicly listed company, subject to certain regulatory requirements.
  • Has a registered office and management team.
  • Previously engaged in legitimate business operations (CBD products).

Imperalis Holding Corp. Financial Services Stock: Key Questions Answered

What does Imperalis Holding Corp. do?

Imperalis Holding Corp. currently operates as a shell company, meaning it does not have significant active business operations. Previously, the company was involved in the development, marketing, and sale of CBD-based personal care products through its subsidiary, CannaCure Sciences, Inc. However, these operations are no longer significant.

What do analysts say about IMHC stock?

As of March 18, 2026, there is no available analyst coverage or consensus on Imperalis Holding Corp. (IMHC) due to its status as a shell company with no significant operations. Key valuation metrics such as price targets and earnings estimates are not applicable.

What are the main risks for IMHC?

The main risks for Imperalis Holding Corp. (IMHC) stem from its status as a shell company with no significant operations. These risks include the potential failure to identify and execute a successful strategic transaction, market conditions impacting capital raising efforts, regulatory changes affecting shell companies and reverse mergers, limited financial disclosure and transparency due to its OTC listing, and low trading volume and liquidity, which can increase price volatility.

What are the key factors to evaluate for IMHC?

Evaluate IMHC on fundamentals, analyst consensus, and risk factors. Imperalis Holding Corp. (IMHC) presents a speculative investment opportunity given its status as a shell company. Not financial advice.

How frequently does IMHC data refresh on this page?

IMHC's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven IMHC's recent stock price performance?

Imperalis Holding Corp. (IMHC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Existing corporate structure. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider IMHC overvalued or undervalued right now?

Imperalis Holding Corp. (IMHC) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

How do I research IMHC before investing?

Before investing in Imperalis Holding Corp. (IMHC), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on publicly available data and may be subject to change.
  • The analysis is limited by the lack of current operations and financial disclosure.
Data Sources

Popular Stocks

More Stocks We Cover